{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T14:16:27Z","timestamp":1784297787646,"version":"3.55.0"},"reference-count":109,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T00:00:00Z","timestamp":1748908800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007368","name":"Fondazione Pisa","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007368","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000921","name":"European Cooperation in Science and Technology","doi-asserted-by":"publisher","award":["CA21116"],"award-info":[{"award-number":["CA21116"]}],"id":[{"id":"10.13039\/501100000921","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Cancer Biology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.semcancer.2025.06.001","type":"journal-article","created":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T11:10:24Z","timestamp":1748862624000},"page":"1-14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Long-term recurrence of PDAC after resection for IPMN: A narrative review of the literature on clinical and biologic predictors"],"prefix":"10.1016","volume":"114","author":[{"given":"Annalisa","family":"Comandatore","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregorio","family":"Di Franco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"Garajov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afrodita","family":"Panaitescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Ausania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Livia","family":"Giannessi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niccol\u00f3","family":"Furbetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Guadagni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Caterina","family":"Milanetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Pasquali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Gentiluomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Corradi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volkan","family":"Adsay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Campa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Giovannetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7742-9556","authenticated-orcid":false,"given":"Luca","family":"Morelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semcancer.2025.06.001_bib1","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/00000658-199602000-00005","article-title":"Mucin-producing neoplasms of the pancreas. Intraductal papillary and mucinous cystic neoplasms","volume":"223","author":"Shyr","year":"1996","journal-title":"Ann. Surg."},{"key":"10.1016\/j.semcancer.2025.06.001_bib2","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1038\/ajg.2010.122","article-title":"Prevalence of incidental pancreatic cysts in the adult population on MR imaging","volume":"105","author":"Lee","year":"2010","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.semcancer.2025.06.001_bib3","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000005535","article-title":"Incidental pancreatic cystic neoplasms in an asymptomatic healthy population of 21,745 individuals: large-scale, single-center cohort study","volume":"95","author":"Chang","year":"2016","journal-title":"Med. (Balt. )"},{"key":"10.1016\/j.semcancer.2025.06.001_bib4","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1136\/gutjnl-2016-313127","article-title":"Prospective study on the incidence, prevalence and 5-year pancreaticrelated mortality of pancreatic cysts in a population-based study","volume":"67","author":"Kromrey","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.semcancer.2025.06.001_bib5","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.pan.2017.07.007","article-title":"Revisions of international consensus Fukuoka guidelines for the management of IPMN of the pancreas","volume":"17","author":"Tanaka","year":"2017","journal-title":"Pancreatology"},{"key":"10.1016\/j.semcancer.2025.06.001_bib6","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1159\/000090023","article-title":"M, t al. International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas","volume":"6","author":"Tanaka","year":"2006","journal-title":"Pancreatology"},{"key":"10.1016\/j.semcancer.2025.06.001_bib7","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1097\/MPA.0b013e31824b22c6","article-title":"Management strategy for multifocal branch duct intraductal papillary mucinous neoplasms of the pancreas","volume":"41","author":"Mori","year":"2012","journal-title":"Pancreas"},{"key":"10.1016\/j.semcancer.2025.06.001_bib8","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.pan.2022.07.004","article-title":"Long-term outcomes of patients with multifocal intraductal papillary mucinous neoplasm following pancreatectomy","volume":"22","author":"Hashimoto","year":"2022","journal-title":"Pancreatology"},{"key":"10.1016\/j.semcancer.2025.06.001_bib9","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.pan.2023.08.002","article-title":"Systematic review of challenging issues in pathology of intraductal papillary mucinous neoplasms","volume":"23","author":"Wood","year":"2023","journal-title":"Pancreatology"},{"key":"10.1016\/j.semcancer.2025.06.001_bib10","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1136\/gut.2010.210567","article-title":"Prognostic relevance of morphological types of intraductal papillary mucinous neoplasms of the pancreas","volume":"60","author":"Furukawa","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.semcancer.2025.06.001_bib11","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/MPA.0000000000000253","article-title":"Molecular biomarkers for progression of intraductal papillary mucinous neoplasm of the pancreas","volume":"44","author":"Kuboki","year":"2015","journal-title":"Pancreas"},{"key":"10.1016\/j.semcancer.2025.06.001_bib12","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.pan.2023.05.005","article-title":"Predictive ability of pancreatic cyst fluid biomarkers: a systematic review and metanalysis","volume":"23","author":"Pfl\u00fcger","year":"2023","journal-title":"Pancreatology"},{"key":"10.1016\/j.semcancer.2025.06.001_bib13","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1097\/MPA.0000000000001047","article-title":"Intraductal papillary mucinous neoplasm of the pancreas as the main focus for early detection of pancreatic adenocarcinoma","volume":"47","author":"Tanaka","year":"2018","journal-title":"Pancreas"},{"key":"10.1016\/j.semcancer.2025.06.001_bib14","first-page":"22","article-title":"Value of EUS in early detection of pancreatic ductal adenocarcinomas in patients with intraductal papillary mucinous neoplasms","volume":"46","author":"Kamata","year":"2014","journal-title":"Endoscopy"},{"key":"10.1016\/j.semcancer.2025.06.001_bib15","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.surg.2017.09.040","article-title":"Surveillance of patients with intraductal papillary mucinous neoplasm with and without pancreatectomy with special reference to the incidence of concomitant pancreatic ductal adenocarcinoma","volume":"163","author":"Date","year":"2018","journal-title":"Surgery"},{"key":"10.1016\/j.semcancer.2025.06.001_bib16","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1097\/MPA.0b013e318215010c","article-title":"Pancreatic ductal adenocarcinoma derived from IPMN and pancreatic ductal adenocarcinoma concomitant with IPMN","volume":"40","author":"Yamaguchi","year":"2011","journal-title":"Pancreas"},{"key":"10.1016\/j.semcancer.2025.06.001_bib17","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1053\/j.gastro.2018.05.035","article-title":"Risk of neoplastic progression in individuals at high risk for pancreatic cancer undergoing long-term surveillance","volume":"155","author":"Canto","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.semcancer.2025.06.001_bib18","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.pan.2012.05.011","article-title":"Intraductal papillary mucinous neoplasms: does a family history of pancreatic cancer matter?","volume":"12","author":"Nehra","year":"2012","journal-title":"Pancreatology"},{"key":"10.1016\/j.semcancer.2025.06.001_bib19","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.pan.2012.04.004","article-title":"International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas","volume":"12","author":"Tanaka","year":"2012","journal-title":"Pancreatology"},{"key":"10.1016\/j.semcancer.2025.06.001_bib20","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.pan.2023.12.009","article-title":"International evidence-based Kyoto guidelines for the management of intraductal papillary mucinous neoplasm of the pancreas","volume":"24","author":"Ohtsuka","year":"2024","journal-title":"Pancreatology"},{"key":"10.1016\/j.semcancer.2025.06.001_bib21","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.surg.2011.07.009","article-title":"An increase in the number of predictive factors augments the likelihood of malignancy in branch duct intraductal papillary mucinous neoplasm of the pancreas","volume":"151","author":"Ohtsuka","year":"2012","journal-title":"Surgery"},{"key":"10.1016\/j.semcancer.2025.06.001_bib22","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1097\/XCS.0000000000000176","article-title":"Number of worrisome features and risk of malignancy in intradutal papillary mucinous neoplasm","volume":"234","author":"Zelga","year":"2022","journal-title":"J. Am. Coll. Surg."},{"key":"10.1016\/j.semcancer.2025.06.001_bib23","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.pan.2023.02.008","article-title":"Surveillance after resection of non-invasive intraductal papillary mucinous neoplasms (IPMN). A systematic review","volume":"23","author":"Correa-Gallego","year":"2023","journal-title":"Pancreatology"},{"key":"10.1016\/j.semcancer.2025.06.001_bib24","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.gie.2016.09.027","article-title":"Comparing 3 guidelines on the management of surgically removed pancreatic cysts with regard to pathological outcome","volume":"85","author":"Lekkerkerker","year":"2017","journal-title":"Gastrointest. Endosc."},{"key":"10.1016\/j.semcancer.2025.06.001_bib25","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1111\/den.13626","article-title":"Diagnostic performance of endoscopic ultrasound through-the-needle microforceps biopsy of pancreatic cystic lesions: systematic review with meta-analysis","volume":"32","author":"Tacelli","year":"2020","journal-title":"Dig. Endosc."},{"key":"10.1016\/j.semcancer.2025.06.001_bib26","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1245\/ASO.2006.05.002","article-title":"Intraductal papillary mucinous neoplasms of the pancreas: effect of invasion and pancreatic margin status on recurrence and survival","volume":"13","author":"Raut","year":"2006","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.semcancer.2025.06.001_bib27","doi-asserted-by":"crossref","first-page":"e231","DOI":"10.1097\/SLA.0000000000004478","article-title":"Fate of patients with intraductal papillary mucinous neoplasms of pancreas after resection according to the pathology and margin status: continuously increasing risk of recurrence even after curative resection suggesting necessity of lifetime surveillance","volume":"276","author":"Kim","year":"2022","journal-title":"Ann. Surg."},{"key":"10.1016\/j.semcancer.2025.06.001_bib28","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/SLA.0b013e3182a690ff","article-title":"Treatment strategy for main duct intraductal papillary mucinous neoplasms of the pancreas based on the assessment of recurrence in the remnant pancreas after resection: a retrospective review","volume":"259","author":"Tamura","year":"2014","journal-title":"Ann. Surg."},{"key":"10.1016\/j.semcancer.2025.06.001_bib29","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1111\/j.1477-2574.2011.00354.x","article-title":"Outcome of the pancreatic remnant following segmental pancreatectomy for non-invasive intraductal papillary mucinous neoplasm","volume":"13","author":"Miller","year":"2011","journal-title":"HPB Oxf."},{"key":"10.1016\/j.semcancer.2025.06.001_bib30","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.jamcollsurg.2012.12.026","article-title":"Is it necessary to follow patients after resection of a benign pancreatic intraductal papillary mucinous neoplasm?","volume":"216","author":"He","year":"2013","journal-title":"J. Am. Coll. Surg."},{"key":"10.1016\/j.semcancer.2025.06.001_bib31","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1097\/SLA.0000000000004488","article-title":"Invasive and non-invasive progression after resection of non-invasive intraductal papillary mucinous neoplasms","volume":"276","author":"Amini","year":"2022","journal-title":"Ann. Surg."},{"key":"10.1016\/j.semcancer.2025.06.001_bib32","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.surg.2010.03.013","article-title":"Prognostic impact of pancreatic margin status in the intraductal papillary mucinous neoplasms of the pancreas","volume":"148","author":"Fujii","year":"2010","journal-title":"Surgery"},{"key":"10.1016\/j.semcancer.2025.06.001_bib33","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1111\/hpb.12137","article-title":"Dysplasia at the surgical margin is associated with recurrence after resection of non-invasive intraductal papillary mucinous neoplasms","volume":"15","author":"Frankel","year":"2013","journal-title":"HPB Oxf."},{"key":"10.1016\/j.semcancer.2025.06.001_bib34","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/SLA.0000000000002923","article-title":"Does surgical margin impact recurrence in noninvasive intraductal papillary mucinous neoplasms?: a multi-institutional study","volume":"268","author":"Dhar","year":"2018","journal-title":"Ann. Surg."},{"key":"10.1016\/j.semcancer.2025.06.001_bib35","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.hpb.2015.10.010","article-title":"Intraductal papillary mucinous neoplasm (IPMN) with high grade dysplasia is a risk factor for the subsequent development of pancreatic ductal adenocarcinoma","volume":"18","author":"Rezaee","year":"2016","journal-title":"HPB Oxf."},{"key":"10.1016\/j.semcancer.2025.06.001_bib36","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/s41395-018-0403-2","article-title":"High-grade dysplasia in resected main-duct intraductal papillary mucinous neoplasm (MD-IPMN) is associated with an increased risk of subsequent pancreatic cancer","volume":"114","author":"Majumder","year":"2019","journal-title":"Am. J. Gastroenterol."},{"issue":"5","key":"10.1016\/j.semcancer.2025.06.001_bib37","article-title":"European evidence-based guidelines on pancreatic cystic neoplasms","volume":"67","author":"Del Chiaro","year":"2018","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.semcancer.2025.06.001_bib38","doi-asserted-by":"crossref","DOI":"10.3390\/jcm13030830","article-title":"Recurrence following Resection of Intraductal Papillary Mucinous Neoplasms: A Systematic Review to Guide Surveillance","volume":"13","author":"Salahuddin","year":"2024","journal-title":"J. Clin. Med"},{"issue":"2","key":"10.1016\/j.semcancer.2025.06.001_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.pan.2023.12.009","article-title":"International evidence-based Kyoto guidelines for the management of intraductal papillary mucinous neoplasm of the pancreas","volume":"24","author":"Ohtsuka","year":"2024","journal-title":"Pancreatology"},{"issue":"5","key":"10.1016\/j.semcancer.2025.06.001_bib40","doi-asserted-by":"crossref","DOI":"10.1038\/s41379-019-0405-7","article-title":"Metachronous intraductal papillary mucinous neoplasms disseminate via the pancreatic duct following resection","volume":"33","author":"Nagai","year":"2020","journal-title":"Mod. Pathol."},{"issue":"5","key":"10.1016\/j.semcancer.2025.06.001_bib41","doi-asserted-by":"crossref","DOI":"10.1097\/SLA.0000000000001755","article-title":"Molecular Evidence for Monoclonal Skip Progression in Main Duct Intraductal Papillary Mucinous Neoplasms of the Pancreas","volume":"265","author":"Date","year":"2017","journal-title":"Ann. Surg."},{"issue":"6","key":"10.1016\/j.semcancer.2025.06.001_bib42","doi-asserted-by":"crossref","DOI":"10.1097\/SLA.0000000000001368","article-title":"Predictive factors for the metachronous development of high-risk lesions in the remnant pancreas after partial pancreatectomy for intraductal papillary mucinous Neoplasm","volume":"263","author":"Miyasaka","year":"2016","journal-title":"Ann. Surg."},{"issue":"5","key":"10.1016\/j.semcancer.2025.06.001_bib43","doi-asserted-by":"crossref","DOI":"10.1097\/SLA.0000000000003060","article-title":"Concomitant Intraductal Papillary Mucinous Neoplasm in Pancreatic Ductal Adenocarcinoma Is an Independent Predictive Factor for the Occurrence of New Cancer in the Remnant Pancreas","volume":"271","author":"Matsuda","year":"2020","journal-title":"Ann. Surg."},{"issue":"1","key":"10.1016\/j.semcancer.2025.06.001_bib44","doi-asserted-by":"crossref","DOI":"10.1097\/SLA.0000000000001817","article-title":"Targeted DNA Sequencing Reveals Patterns of Local Progression in the Pancreatic Remnant Following Resection of Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas","volume":"266","author":"Pea","year":"2017","journal-title":"Ann. Surg."},{"issue":"3","key":"10.1016\/j.semcancer.2025.06.001_bib45","doi-asserted-by":"crossref","DOI":"10.1038\/s41395-018-0403-2","article-title":"High-Grade Dysplasia in Resected Main-Duct Intraductal Papillary Mucinous Neoplasm (MD-IPMN) is Associated with an Increased Risk of Subsequent Pancreatic Cancer","volume":"114","author":"Majumder","year":"2019","journal-title":"Am. J. Gastroenterol."},{"issue":"3","key":"10.1016\/j.semcancer.2025.06.001_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.hpb.2015.10.010","article-title":"Intraductal papillary mucinous neoplasm (IPMN) with high-grade dysplasia is a risk factor for the subsequent development of pancreatic ductal adenocarcinoma","volume":"18","author":"Rezaee","year":"2016","journal-title":"HPB"},{"issue":"2","key":"10.1016\/j.semcancer.2025.06.001_bib47","doi-asserted-by":"crossref","DOI":"10.1097\/SLA.0b013e3182a690ff","article-title":"Treatment strategy for main duct intraductal papillary mucinous neoplasms of the pancreas based on the assessment of recurrence in the remnant pancreas after resection: A retrospective review","volume":"259","author":"Tamura","year":"2014","journal-title":"Ann. Surg."},{"issue":"4","key":"10.1016\/j.semcancer.2025.06.001_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.pan.2012.05.011","article-title":"Intraductal papillary mucinous neoplasms: Does a family history of pancreatic cancer matter?","volume":"12","author":"Nehra","year":"2012","journal-title":"Pancreatology"},{"issue":"6","key":"10.1016\/j.semcancer.2025.06.001_bib49","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1097\/RCT.0b013e3181a7e2a8","article-title":"Recurrence Patterns of Intraductal Papillary Mucinous Neoplasms of the Pancreas on Enhanced Computed Tomography","volume":"33","author":"Landa","year":"2009","journal-title":"J. Comput. Assist Tomogr."},{"issue":"5","key":"10.1016\/j.semcancer.2025.06.001_bib50","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1097\/SLA.0000000000000813","article-title":"IPMN Involving the Main Pancreatic Duct","volume":"261","author":"Marchegiani","year":"2015","journal-title":"Ann. Surg."},{"issue":"2","key":"10.1016\/j.semcancer.2025.06.001_bib51","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.pan.2023.12.009","article-title":"International evidence-based Kyoto guidelines for the management of intraductal papillary mucinous neoplasm of the pancreas","volume":"24","author":"Ohtsuka","year":"2024","journal-title":"Pancreatology"},{"issue":"3","key":"10.1016\/j.semcancer.2025.06.001_bib52","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.pan.2012.04.004","article-title":"International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas","volume":"12","author":"Tanaka","year":"2012","journal-title":"Pancreatology"},{"issue":"4","key":"10.1016\/j.semcancer.2025.06.001_bib53","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1053\/j.gastro.2015.01.015","article-title":"American Gastroenterological Association Institute Guideline on the Diagnosis and Management of Asymptomatic Neoplastic Pancreatic Cysts","volume":"148","author":"Vege","year":"2015","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.semcancer.2025.06.001_bib54","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s00535-019-01617-2","article-title":"Recurrence patterns after surgical resection of intraductal papillary mucinous neoplasm (IPMN) of the pancreas; a multicenter, retrospective study of 1074 IPMN patients by the Japan Pancreas Society","volume":"55","author":"Hirono","year":"2020","journal-title":"J. Gastroenterol."},{"issue":"2","key":"10.1016\/j.semcancer.2025.06.001_bib55","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1097\/SLA.0000000000000470","article-title":"Long-term Prospective Cohort Study of Patients Undergoing Pancreatectomy for Intraductal Papillary Mucinous Neoplasm of the Pancreas","volume":"260","author":"Kang","year":"2014","journal-title":"Ann. Surg."},{"issue":"5","key":"10.1016\/j.semcancer.2025.06.001_bib56","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.2214\/ajr.183.5.1831367","article-title":"Intraductal Papillary Mucinous Neoplasms of the Pancreas: CT Patterns of Recurrence and Multiobserver Performance in Detecting Recurrent Neoplasm After Surgical Resection","volume":"183","author":"Christensen","year":"2004","journal-title":"Am. J. Roentgenol."},{"issue":"5","key":"10.1016\/j.semcancer.2025.06.001_bib57","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/den.13176","article-title":"Value of additional endoscopic ultrasonography for surveillance after surgical removal of intraductal papillary mucinous neoplasms","volume":"30","author":"Kamata","year":"2018","journal-title":"Dig. Endosc."},{"issue":"5","key":"10.1016\/j.semcancer.2025.06.001_bib58","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.pan.2017.07.007","article-title":"Revisions of internationaconsensus Fukuoka guidelines for the management of IPMN of the pancreas","volume":"17","author":"Tanaka","year":"2017","journal-title":"Pancreatology"},{"issue":"3","key":"10.1016\/j.semcancer.2025.06.001_bib59","doi-asserted-by":"crossref","first-page":"830","DOI":"10.3390\/jcm13030830","article-title":"Recurrence following Resection of Intraductal Papillary Mucinous Neoplasms: A Systematic Review to Guide Surveillance","volume":"13","author":"Salahuddin","year":"2024","journal-title":"J. Clin. Med."},{"issue":"5","key":"10.1016\/j.semcancer.2025.06.001_bib60","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1136\/gutjnl-2018-316027","article-title":"European evidence-based guidelines on pancreatic cystic neoplasms","volume":"67","author":"European Study Group on Cystic Tumours of the Pancreas","year":"2018","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.semcancer.2025.06.001_bib61","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.pan.2023.12.009","article-title":"International evidence-based Kyoto guidelines for the management of intraductal papillary mucinous neoplasm of the pancreas","volume":"24","author":"Ohtsuka","year":"2024","journal-title":"Pancreatol.: Off. J. Int. Assoc. Pancreatol. (IAP) \u2026 [Et. al. ]"},{"issue":"1","key":"10.1016\/j.semcancer.2025.06.001_bib62","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1097\/SLA.0000000000006144","article-title":"Risk of Recurrence After Surgical Resection for Adenocarcinoma Arising From Intraductal Papillary Mucinous Neoplasia (IPMN) With Patterns of Distribution and Treatment: An International, Multicenter, Observational Study (ADENO-IPMN Study)","volume":"280","author":"Lucocq","year":"2024","journal-title":"Ann. Surg."},{"issue":"1","key":"10.1016\/j.semcancer.2025.06.001_bib63","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1186\/s12885-022-09650-w","article-title":"Optimal surveillance of intraductal papillary mucinous neoplasms of the pancreas focusing on remnant pancreas recurrence after surgical resection","volume":"22","author":"Fuji","year":"2022","journal-title":"BMC Cancer"},{"issue":"6","key":"10.1016\/j.semcancer.2025.06.001_bib64","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1097\/SLA.0000000000001008","article-title":"Patterns of Recurrence After Resection of IPMN: Who, When, and How?","volume":"262","author":"Marchegiani","year":"2015","journal-title":"Ann. Surg."},{"issue":"3","key":"10.1016\/j.semcancer.2025.06.001_bib65","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.pan.2016.02.008","article-title":"Management implications of resection margin histology in patients undergoing resection for IPMN: A meta-analysis","volume":"16","author":"Bhardwaj","year":"2016","journal-title":"Pancreatol.: Off. J. Int. Assoc. Pancreatol. (IAP) \u2026 [Et. al. ]"},{"issue":"3","key":"10.1016\/j.semcancer.2025.06.001_bib66","doi-asserted-by":"crossref","first-page":"366","DOI":"10.5858\/arpa.2016-0262-SA","article-title":"The Evolving Role of Pathology in New Developments, Classification, Terminology, and Diagnosis of Pancreatobiliary Neoplasms","volume":"141","author":"Reid","year":"2017","journal-title":"Arch. Pathol. Lab Med"},{"issue":"23","key":"10.1016\/j.semcancer.2025.06.001_bib67","doi-asserted-by":"crossref","first-page":"12839","DOI":"10.3390\/ijms222312839","article-title":"Humoral Predictors of Malignancy in IPMN: A Review of the Literature","volume":"22","author":"Nista","year":"2021","journal-title":"Int J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.semcancer.2025.06.001_bib68","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.pan.2023.11.015","article-title":"Serum elastase-1 predicts malignancy in intraductal papillary mucinous neoplasm of the pancreas","volume":"24","author":"Mishima","year":"2024","journal-title":"Pancreatology"},{"issue":"1","key":"10.1016\/j.semcancer.2025.06.001_bib69","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-57930-x","article-title":"CA19-9 for detecting recurrence of pancreatic cancer","volume":"10","author":"Azizian","year":"2020","journal-title":"Sci. Rep."},{"issue":"16","key":"10.1016\/j.semcancer.2025.06.001_bib70","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241612604","article-title":"Screening of Exosome-Derived Proteins and Their Potential as Biomarkers in Diagnostic and Prognostic for Pancreatic Cancer","volume":"24","author":"Marin","year":"2023","journal-title":"Int J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.semcancer.2025.06.001_bib71","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.31197","article-title":"Prediction Model for Early-Stage Pancreatic Cancer Using Routinely Measured Blood Biomarkers","volume":"6","author":"Boyd","year":"2023","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.semcancer.2025.06.001_bib72","unstructured":"Akinfemiwa O., Zubair M., Muniraj T.. Amylase. StatPearls [Internet]. 2023 Nov 12 [cited 2024 Nov 5]; Available from: \u3008https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK557738\/\u3009."},{"issue":"4","key":"10.1016\/j.semcancer.2025.06.001_bib73","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1245\/s10434-015-4934-0","article-title":"Predictive Value of Neutrophil\/Lymphocyte Ratio for Efficacy of Preoperative Chemotherapy in Triple-Negative Breast Cancer","volume":"23","author":"Asano","year":"2015","journal-title":"Ann. Surg. Oncol. [Internet]"},{"issue":"3","key":"10.1016\/j.semcancer.2025.06.001_bib74","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.amjsurg.2015.03.022","article-title":"Clinical significance of preoperative neutrophil-lymphocyte vs platelet-lymphocyte ratio in primary operable patients with non-small cell lung cancer","volume":"210","author":"Zhang","year":"2015","journal-title":"Am. J. Surg. [Internet]"},{"issue":"2","key":"10.1016\/j.semcancer.2025.06.001_bib75","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.amjsurg.2014.06.014","article-title":"Prognostic value of preoperative neutrophils to lymphocytes ratio in patients resected for gastric cancer","volume":"209","author":"Graziosi","year":"2015","journal-title":"Am. J. Surg. [Internet]"},{"issue":"10","key":"10.1016\/j.semcancer.2025.06.001_bib76","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/j.hpb.2021.04.001","article-title":"The diagnostic and prognostic values of inflammatory markers in intraductal papillary mucinous neoplasm","volume":"23","author":"Kim","year":"2021","journal-title":"HPB"},{"issue":"5","key":"10.1016\/j.semcancer.2025.06.001_bib77","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.ctrv.2011.09.001","article-title":"The role of the in situ local inflammatory response in predicting recurrence and survival in patients with primary operable colorectal cancer","volume":"38","author":"Roxburgh","year":"2012","journal-title":"Cancer Treat. Rev. [Internet]"},{"issue":"5","key":"10.1016\/j.semcancer.2025.06.001_bib78","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.hpb.2017.12.009","article-title":"A meta-analysis of the utility of the neutrophil-to-lymphocyte ratio in predicting survival after pancreatic cancer resection","volume":"20","author":"Mowbray","year":"2018","journal-title":"HPB (Oxf. ) [Internet]"},{"issue":"7","key":"10.1016\/j.semcancer.2025.06.001_bib79","doi-asserted-by":"crossref","first-page":"3636","DOI":"10.3390\/ijms23073636","article-title":"Neutrophil to Lymphocyte Ratio: An Emerging Marker of the Relationships between the Immune System and Diseases","volume":"23","author":"Buonacera","year":"2022","journal-title":"Int J. Mol. Sci. [Internet]"},{"issue":"10","key":"10.1016\/j.semcancer.2025.06.001_bib80","first-page":"1239","article-title":"Angiogenesis index CD105 (Endoglin)\/CD31 (PECAM-1) as a predictive factor for invasion and proliferation in intraductal papillary mucinous neoplasm (IPMN) of the pancreas","volume":"25","author":"Tachezy","year":"2010","journal-title":"Histol. Histopathol."},{"issue":"4","key":"10.1016\/j.semcancer.2025.06.001_bib81","first-page":"883","article-title":"Role of lymphangiogenesis and lymphangiogenic factors during pancreatic cancer progression and lymphatic spread","volume":"28","author":"Schneider","year":"2006","journal-title":"Int J. Oncol."},{"issue":"3","key":"10.1016\/j.semcancer.2025.06.001_bib82","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/mpa.0b013e3181690b97","article-title":"Specific expression of endoglin (CD105) in endothelial cells of intratumoral blood and lymphatic vessels in pancreatic cancer","volume":"37","author":"Yoshitomi","year":"2008","journal-title":"Pancreas"},{"key":"10.1016\/j.semcancer.2025.06.001_bib83","doi-asserted-by":"crossref","unstructured":"Kuboki Y., Shimizu K., Hatori T., Yamamoto M., Shibata N., Shiratori K., et al. Molecular Biomarkers for Progression of Intraductal Papillary Mucinous Neoplasm of the Pancreas [Internet]. 2014. Available from: \u3008www.pancreasjournal.com\u3009.","DOI":"10.1097\/MPA.0000000000000253"},{"key":"10.1016\/j.semcancer.2025.06.001_bib84","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.path.2016.04.008","article-title":"Molecular Diagnostics in the Evaluation of Pancreatic Cysts","volume":"9","author":"Theisen","year":"2016","journal-title":"Surg. Pathol. Clin. W. B. Saunders"},{"issue":"13","key":"10.1016\/j.semcancer.2025.06.001_bib85","first-page":"1","article-title":"SDC1 and ITGA2 as novel prognostic biomarkers for PDAC related to IPMN","volume":"1","author":"Zhang","year":"2023","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.semcancer.2025.06.001_bib86","doi-asserted-by":"crossref","first-page":"628","DOI":"10.3390\/cancers15030628","article-title":"Prognostic Significance of Integrin Subunit Alpha 2 (ITGA2) and Role of Mechanical Cues in Resistance to Gemcitabine in Pancreatic Ductal Adenocarcinoma (PDAC)","volume":"15","author":"Gregori","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"5","key":"10.1016\/j.semcancer.2025.06.001_bib87","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1002\/ijc.28765","article-title":"Genome-wide DNA methylation patterns in pancreatic ductal adenocarcinoma reveal epigenetic deregulation of SLIT-ROBO, ITGA2 and MET signaling","volume":"135","author":"Nones","year":"2014","journal-title":"Int J. Cancer [Internet]"},{"issue":"6","key":"10.1016\/j.semcancer.2025.06.001_bib88","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.hbpd.2020.05.007","article-title":"Role of phosphorylated Smad3 signal components in intraductal papillary mucinous neoplasm of pancreas","volume":"19","author":"Hori","year":"2020","journal-title":"Hepatobiliary Pancreat. Dis. Int."},{"issue":"2","key":"10.1016\/j.semcancer.2025.06.001_bib89","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s00535-011-0482-y","article-title":"Different subtypes of intraductal papillary mucinous neoplasm in the pancreas have distinct pathways to pancreatic cancer progression","volume":"47","author":"Mohri","year":"2012","journal-title":"J. Gastroenterol."},{"issue":"4","key":"10.1016\/j.semcancer.2025.06.001_bib90","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.pan.2018.04.003","article-title":"Clinicopathological and prognostic significance of MUC13 and AGR2 expression in intraductal papillary mucinous neoplasms of the pancreas","volume":"18","author":"Mito","year":"2018","journal-title":"Pancreatology"},{"issue":"2","key":"10.1016\/j.semcancer.2025.06.001_bib91","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/labinvest.2014.138","article-title":"Anterior gradient 2 downregulation in a subset of pancreatic ductal adenocarcinoma is a prognostic factor indicative of epithelial-mesenchymal transition","volume":"95","author":"Mizuuchi","year":"2015","journal-title":"Lab Invest"},{"key":"10.1016\/j.semcancer.2025.06.001_bib92","article-title":"Molecular Analysis of Pancreatic Cyst Fluid for the Management of Intraductal Papillary Mucinous Neoplasms","volume":"12","author":"Turner","year":"2022","journal-title":"Diagn. Multidiscip. Digit. Publ. Inst. (MDPI)"},{"issue":"7","key":"10.1016\/j.semcancer.2025.06.001_bib93","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.pan.2023.05.005","article-title":"Predictive ability of pancreatic cyst fluid biomarkers: A systematic review and meta-analysis","volume":"23","author":"Pfl\u00fcger","year":"2023","journal-title":"Pancreatology"},{"issue":"1","key":"10.1016\/j.semcancer.2025.06.001_bib94","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jmoldx.2017.09.006","article-title":"Simple Detection of Telomere Fusions in Pancreatic Cancer, Intraductal Papillary Mucinous Neoplasm, and Pancreatic Cyst Fluid","volume":"20","author":"Hata","year":"2018","journal-title":"J. Mol. Diagn."},{"issue":"1","key":"10.1016\/j.semcancer.2025.06.001_bib95","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s11605-007-0383-9","article-title":"Telomere shortening and telomerase expression during multistage carcinogenesis of intraductal papillary mucinous neoplasms of the pancreas","volume":"12","author":"Hashimoto","year":"2008","journal-title":"J. Gastrointest. Surg."},{"key":"10.1016\/j.semcancer.2025.06.001_bib96","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.semcancer.2023.11.003","article-title":"Thinking small to win big? A critical review on the potential application of extracellular vesicles for biomarker discovery and new therapeutic approaches in pancreatic cancer","volume":"97","author":"Vahabi","year":"2023","journal-title":"Semin Cancer Biol."},{"key":"10.1016\/j.semcancer.2025.06.001_bib97","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.cytogfr.2023.07.004","article-title":"Role of exosomes in transferring chemoresistance through modulation of cancer glycolytic cell metabolism","volume":"73","author":"Vahabi","year":"2023","journal-title":"Cytokine Growth Factor Rev."},{"issue":"2","key":"10.1016\/j.semcancer.2025.06.001_bib98","first-page":"286","article-title":"Potential Role of Exosomes in the Chemoresistance to Gemcitabine and Nab-Paclitaxel in Pancreatic Cancer","volume":"12","author":"Comandatore","year":"2022","journal-title":"Diagn. (Basel)"},{"issue":"7","key":"10.1016\/j.semcancer.2025.06.001_bib99","doi-asserted-by":"crossref","DOI":"10.3390\/life13071570","article-title":"Circulating Epithelial Cells in Patients with Intraductal Papillary Mucinous Neoplasm of the Pancreas","volume":"13","author":"Kuvendjiska","year":"2023","journal-title":"Life"},{"issue":"3","key":"10.1016\/j.semcancer.2025.06.001_bib100","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1093\/annonc\/mds513","article-title":"The good, the bad and the ugly: a tale of miR-101, miR-21 and miR-155 in pancreatic intraductal papillary mucinous neoplasms","volume":"24","author":"Caponi","year":"2013","journal-title":"Ann. Oncol."},{"issue":"11","key":"10.1016\/j.semcancer.2025.06.001_bib101","doi-asserted-by":"crossref","first-page":"4528","DOI":"10.1158\/0008-5472.CAN-09-4467","article-title":"MicroRNA-21 in pancreatic cancer: Correlation with clinical outcome and pharmacologic aspects underlying its role in the modulation of gemcitabine activity","volume":"70","author":"Giovannetti","year":"2010","journal-title":"Cancer Res"},{"issue":"12","key":"10.1016\/j.semcancer.2025.06.001_bib102","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1007\/s00432-018-2749-7","article-title":"Circulating microRNA-99 family as liquid biopsy marker in pancreatic adenocarcinoma","volume":"144","author":"Stroese","year":"2018","journal-title":"J. Cancer Res Clin. Oncol."},{"issue":"6","key":"10.1016\/j.semcancer.2025.06.001_bib103","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1097\/SLA.0000000000001809","article-title":"MicroRNAs for detection of pancreatic neoplasia: Biomarker discovery by next-generation sequencing and validation in 2 independent cohorts","volume":"265","author":"Vila-Navarro","year":"2017","journal-title":"Ann. Surg."},{"issue":"16","key":"10.1016\/j.semcancer.2025.06.001_bib104","article-title":"Spatial Transcriptomic Technologies","volume":"12","author":"Chen","year":"2023","journal-title":"Cells [Internet]"},{"issue":"19","key":"10.1016\/j.semcancer.2025.06.001_bib105","doi-asserted-by":"crossref","first-page":"11190","DOI":"10.3390\/ijms231911190","article-title":"Identification of a Novel Renal Metastasis Associated CpG-Based DNA Methylation Signature (RMAMS)","volume":"23","author":"Serth","year":"2022","journal-title":"Int J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.semcancer.2025.06.001_bib106","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1158\/2159-8290.CD-22-1200","article-title":"Spatial Transcriptomics of Intraductal Papillary Mucinous Neoplasms of the Pancreas Identifies NKX6-2 as a Driver of Gastric Differentiation and Indolent Biological Potential","volume":"13","author":"Sans","year":"2023","journal-title":"Cancer Discov."},{"issue":"1","key":"10.1016\/j.semcancer.2025.06.001_bib107","article-title":"Digging deeper into volatile organic compounds associated with cancer","volume":"4","author":"Janfaza","year":"2019","journal-title":"Biol. Methods Protoc. [Internet]"},{"issue":"3","key":"10.1016\/j.semcancer.2025.06.001_bib108","doi-asserted-by":"crossref","first-page":"894","DOI":"10.4251\/wjgo.v16.i3.894","article-title":"Identification of breath volatile organic compounds to distinguish pancreatic adenocarcinoma, pancreatic cystic neoplasm, and patients without pancreatic lesions","volume":"16","author":"Tiankanon","year":"2024","journal-title":"World J. Gastrointest. Oncol."},{"issue":"2","key":"10.1016\/j.semcancer.2025.06.001_bib109","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/s41374-020-00494-1","article-title":"Establishing a living biobank of patient-derived organoids of intraductal papillary mucinous neoplasms of the pancreas","volume":"101","author":"Beato","year":"2021","journal-title":"Lab Invest"}],"container-title":["Seminars in Cancer Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X25000768?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X25000768?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T21:48:45Z","timestamp":1778795325000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1044579X25000768"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":109,"alternative-id":["S1044579X25000768"],"URL":"https:\/\/doi.org\/10.1016\/j.semcancer.2025.06.001","relation":{},"ISSN":["1044-579X"],"issn-type":[{"value":"1044-579X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term recurrence of PDAC after resection for IPMN: A narrative review of the literature on clinical and biologic predictors","name":"articletitle","label":"Article Title"},{"value":"Seminars in Cancer Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semcancer.2025.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}